Status:
COMPLETED
The Effect of Vitamin D Supplementation on Disease Activity Markers in Systemic Lupus Erythematosus (SLE)
Lead Sponsor:
University of Alexandria
Conditions:
Systemic Lupus Erythematosus
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Systemic lupus erythematosus (SLE) is a chronic multi-system inflammatory autoimmune disease. Vitamin D has potent immunomodulatory properties that have promoted its potential use in the treatment of ...
Eligibility Criteria
Inclusion
- Premenopausal women and males of the same body mass index and ethnicity
Exclusion
- Patients with:
- other inflammatory disorders,
- hepatic disease
- renal disease
- malignant disease.
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
248 Patients enrolled
Trial Details
Trial ID
NCT01425775
Start Date
April 1 2010
End Date
May 1 2011
Last Update
August 30 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, University of Alexandria
Alexandria, Egypt, 00203